A randomized trial of a breast/ovarian cancer genetic testing decision aid used as a communication aid during genetic counseling

Psycho-Oncology

Volumn 17, Issue 8, 2008, Pages 844-854

  Wakefield, Claire E ^a,b,c   Meiser, Bettina ^b,d   Homewood, Judi ^a   Taylor, Alan ^a   Gleeson, Margaret ^e   Williams, Rachel ^f   Tucker, Kathy ^b,d   Barlow Stewart, K ^g   Fenton, G ^h   Goodwin, A ^h   Kirk, J ^h   Zodgekar, P ^h   Andrews, L ^b   Koehler, J ^b   Overkov, A ^b   Peate, M ^b   Tyler, J ^b   Warner, B ^b   Dudding, T ⁱ   Groombridge, C ⁱ   O'Donnell, S ⁱ   Spigelman, A ⁱ   McMahon, C ^a   Hossack, L ^j   Kentwell, M ^j   Young, M ^j   Aragona, C ^k   D'Souza, R ^k   Gaff, C ^k   Hodgkin, L ^k   Ward, R ^f   Butow, P ^l   Lobb, E ^l   more..

^a MACQUARIE UNIVERSITY   (Australia)

^b PRINCE OF WALES HOSPITAL   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

^e Hunter Family Cancer Service   (Australia)

^f ST VINCENT S HOSPITAL   (Australia)

^g Centre for Genetics Education   (Australia)

^h WESTMEAD HOSPITAL   (Australia)

ⁱ Hunter Genetics   (Australia)

^j PETER MACCALLUM CANCER CENTRE   (Australia)

^k ROYAL MELBOURNE HOSPITAL   (Australia)

^l UNIVERSITY OF SYDNEY   (Australia)

more..

Author keywords

Cancer; Decision aid; Genetic testing; Hereditary breast ovarian cancer; Implementation; Oncology

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RISK; CLINICAL DECISION MAKING; CLINICAL TRIAL; COMMUNICATION AID; CONFLICT; CONSULTATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GENETIC COUNSELING; GENETIC SCREENING; HUMAN; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; OVARY CANCER; PATIENT ATTITUDE; PATIENT EDUCATION; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT;

ADULT; AGED; BREAST NEOPLASMS; COMMUNICATION; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC COUNSELING; GENETIC SCREENING; HELPING BEHAVIOR; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; POINT MUTATION; QUESTIONNAIRES; YOUNG ADULT;

EID: 51649083576     PISSN: 10579249     EISSN: 10991611     Source Type: Journal    
DOI: 10.1002/pon.1353     Document Type: Article

References (44)

1. O'Connor AM, Rostom A, Fiset V et al. Decision aids for patients facing health treatment or screening decisions: systematic review. Br Med J 1999;731-734.
2. Feldman-Stewart D, Brennenstuhl S, McIssac K et al. A systematic review of information in decision aids. Health Expect 2007; 10(1):46-61.
3. O'Connor AM. Decision aids for patients considering options affecting cancer outcomes: evidence of efficacy and policy implications. J Natl Cancer Inst 1999;25:67-80.
4. O'Connor AM, Stacey D, Entwistle V et al. Decision aids for people facing health treatment or screening decisions [update of Cochrane Database Syst Rev. 2001;(3)]. Cochrane Database Syst Rev 2003; 2.
5. Wakefield C, Meiser B, Homewood J et al. Development and pilot testing of two decision aids for individuals considering genetic testing for cancer risk. J Genet Couns 2007;16(3):325-339.
6. van Roosmalen MS, Stalmeier PF, Verhoef LC et al. Randomised trial of a decision aid and its timing for women being tested for a BRCA1/2 mutation. Br J Cancer 2004;90(2):333-342.
7. van Roosmalen MS, Stalmeier PF, Verhoef LC et al. Randomized trial of a shared decision-making intervention consisting of trade-offs and individualized treatment information for BRCA1/2 mutation carriers. J Clin Oncol 2004;22(16):3293-3301.
8. Green MJ, Peterson SK, Baker MW et al. Use of an educational computer program before genetic counseling for breast cancer susceptibility: effects on duration and content of counseling sessions. Genet Med 2005;7(4):221-229.
9. Green MJ, Peterson SK, Baker MW et al. Effect of a computer-based decision aid on knowledge, perceptions, and intentions about genetic testing for breast cancer susceptibility: a randomized controlled trial. J Am Med Assoc 2004;292(4):442-452.
10. Schwartz M, Benkendorf JL, Lerman C, Isaacs C, Ryan-Roberston A, Johnson L. Impact of educational print materials on knowledge, attitudes and interest in BRCA1/BRCA2 testing among Ashkenazi Jewish women. Cancer 2001;92(4):932-940.
11. Schwartz M, Valdimarsdottir H, DeMarco T, Lawrence W, Peshkin B. A randomized trial of a decision aid for BRCA1/2 mutation carriers. Psycho-Oncology 2007;16(9 Suppl):S21.
12. Lerman C, Biesecker B, Benkendorf JL et al. Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing. J Natl Cancer Inst 1997;89(2):148-157.
13. Thewes B, Meiser B, Taylor A et al. The fertility- and menopause-related information needs of younger women with a diagnosis of early breast cancer. J Clin Oncol 2005;23(22):5155-5165.
14. O'Connor A, Tugwell P, Welles GA et al. Randomized trial of a portable, self-administered decision aid for postmenopausal women considering long-term preventative hormone replacement therapy. Med Decis Making 1998;18:295-303.
15. Elwyn G, O'Connor A, Stacey D et al. Developing a quality criteria framework for patient decision aids: online international Delphi consensus process. Br Med J 2006;333(7565):417.
16. Wakefield C, Meiser B, Homewood J et al. A randomized controlled trial of a decision aid for women considering genetic testing for breast and ovarian cancer risk. Breast Cancer Res Treat 2008; 107:289-301.
17. O'Cathain A, Thomas K. Evaluating decision aids - where next? Health Expect 2004;7:98-103.
18. Australian Cancer Network. Guidelines on Familial Aspects of Cancer. Australian Cancer Network: Sydney, 1999.
19. National Breast Cancer Centre. Current Best Advice About Familial Aspects of Breast/Ovarian Cancer. NHMRC National Breast Cancer Centre: Sydney, 2000.
20. Centre for Genetics Education. Centre for genetics education web site . Accessed January 19, 2007. NSW Health, 2007.
21. O'Connor AM, Stacey D, Entwistle V et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev 2006;1:1.
22. O'Connor AM. Validation of a Decisional Conflict Scale. Med Decis Making 1995;15(1):25-30.
23. Ottawa Health Decision Centre at the Ottawa Health Research Institute. User Manual - Decisional Conflict Scale(s) . Accessed. University of Ottawa, 2006.
24. Michie S, Dormandy E, Marteau TM. The multi-dimensional measure of informed choice: a validation study. Patient Educ Couns 2002; 48(1):87-91.
25. Horowitz MJ, Wilner N, Alvarez W. Impact of Event Scale: A measure of subjective stress. Psychosom Med 1979;41:209-218.
26. Thewes B, Meiser B, Hickie IB et al. Psychometric properties of the Impact of Event Scale amongst women at increased risk for hereditary breast cancer. Psycho-Oncology 2001;10(6):459-468.
27. Zigmond A, Snaith R. The Hospital Anxiety and Depression Scale. Psychiatr Scand 1983;67:361.
28. Ibbotson T, Maguire P, Selby P, Priestman T, Wallace L. Screening for anxiety and depression in cancer patients: the effects of disease and treatment. Eur J Cancer 1994;30A(1):37-40.
29. Johnston M, Pollard B, Hennessey P. Construct validation of the hospital anxiety and depression scale with clinical populations. J Psychosom Res 2000;48:579-584.
30. Brehaut JC, O'Connor AM, Wood TJ et al. Validation of a Decision Regret Scale. Med Decis Making 2003;23(4):281-292.
31. SPSS Inc. Statistical Program for the Social Sciences: Release 14.0. SPSS Inc.: Chicago, IL, 2005.
32. StataCorp. Stata Statistical Software: Release 9.0. StataCorp: College Station, TX, 2005.
33. Williams RL. A note on robust variance estimation for cluster-correlated data. Biometrics 2000;56: 645-646.
34. Cohen J. Statistical Power Analysis for the Behavioural Sciences (2nd edn). Academic Press: New York: 1988.
35. Norman G, Sloan J, Wyrwich K. Interpretation of changes in health-related quality of life. Med Care 2003; 41(5):562-582.
36. Mireskandari S, Meiser B, Sherman K, Warner BJ, Andrews L, Tucker KM. Evaluation of the needs and concerns of partners of women at high risk of developing breast/ovarian cancer. Psycho-Oncology 2006; 15(2):96-108.
37. Manne S, Audrain J, Schwartz M, Main D, Finch C, Lerman C. Associations between relationship support and psychological reactions of participants and partners to BRCA1 and BRCA2 testing in a clinic-based sample. Ann Behav Med 2004;28(3): 211-225.
38. Bekker HL, Legare F, Stacey D, O'Connor A, Lemyre L. Is anxiety a suitable measure of decision aid effectiveness: a systematic review? Patient Educ Couns 2003/7;50(3):255-262.
39. Rowe HJ, Fisher JR, Quinlivan JA. Are pregnant Australian women well informed about prenatal genetic screening? A systematic investigation using the Multidimensional Measure of Informed Choice [see comment]. Aust N Z J Obstet Gynaecol 2006;46(5): 433-439.
40. Kasparian NA, Wakefield CE, Meiser B. Assessment of psychosocial outcomes in genetic counseling research: an overview of available measurement scales. J Genet Couns 2007;16(6):693-712.
41. O'Donnell S, Cranney A, Jacobsen MJ, Graham ID, O'Connor AM, Tugwell P. Understanding and overcoming the barriers of implementing patient decision aids in clinical practice. J Eval Clin Pract 2006; 12(2):174-181.
42. Silvia KA, Sepucha KR. Decision aids in routine practice: lessons from the breast cancer initiative. Health Expect 2006; 9(3):255-264.
43. Charles C, Gafni A, Whelan T et al. Treatment decision aids: conceptual issues and future directions. Health Expect 2005; 8(2):114-125.
44. Australian Bureau of Statistics. Australian Social Trends 2006. Australian Bureau of Statistics: Canberra, 2006.